Birmingham University is set to take part in a a new trial stromal cell immunotherapy for chronic liver disease.
Up to 56 patients are being recruited to take part in the MERLIN trial, which will investigate the safety and efficacy of a new cellular immunotherapy in patients with either Primary Sclerosing Cholangitis (PSC) or Autoimmune Hepatitis (AIH).
Amazing new trials thanks for posting, science and those dedicated to it, is truly wonderful. Hope for those with immune issues I pray for it’s success. Perhaps one day PBC May be added.
Good morning Richard,
Thank you very much indeed for making us all aware of this new trial.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.